Should patient enrollment criteria for anti-VEGF phase III trials be reconsidered
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Journal of diabetes - 15(2023), 10 vom: 21. Okt., Seite 911-912 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hanhart, Joel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Clinical Trial, Phase III |
|---|
| Anmerkungen: |
Date Completed 26.10.2023 Date Revised 22.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/1753-0407.13468 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM362278067 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM362278067 | ||
| 003 | DE-627 | ||
| 005 | 20231226090914.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/1753-0407.13468 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1207.xml |
| 035 | |a (DE-627)NLM362278067 | ||
| 035 | |a (NLM)37731062 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hanhart, Joel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Should patient enrollment criteria for anti-VEGF phase III trials be reconsidered |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.10.2023 | ||
| 500 | |a Date Revised 22.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Clinical Trial, Phase III | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Vascular Endothelial Growth Factor A |2 NLM | |
| 700 | 1 | |a Jeon, Sohee |e verfasserin |4 aut | |
| 700 | 1 | |a Tuuminen, Raimo |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of diabetes |d 2009 |g 15(2023), 10 vom: 21. Okt., Seite 911-912 |w (DE-627)NLM200002139 |x 1753-0407 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2023 |g number:10 |g day:21 |g month:10 |g pages:911-912 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/1753-0407.13468 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2023 |e 10 |b 21 |c 10 |h 911-912 | ||